版本:
中国

BRIEF-Loxo Oncology reports acceptance of larotrectinib oral presentations at ASCO annual meeting

April 5 Loxo Oncology Inc:

* Loxo Oncology announces acceptance of larotrectinib oral presentations at the American Society Of Clinical Oncology (asco) annual meeting Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐